Researchers randomly assigned 202 depressed older adults (average age, 53 years old, 75% women) to four conditions: supervised group exercise 3 times a week, at-home aerobic exercise (unsupervised), sertraline, 50-200 mg/day, or placebo.
Read More
While few psychiatrists specialize in eating disorders, most of us see patients with anorexia or bulimia from time to time. It’s hard to keep up on the latest literature when we see such patients rarely. As you’ll read in this article, eating disorders are still among the most challenging treatment issues in psychiatry.
Read More
Dr. Bulik, I first learned about your work when I reviewed your book, Runaway Eating, which I rated as the best book for patients on eating disorders. I know that one of the reasons that you gave the book that title is that many patients don’t quite fit the conventional diagnostic categories of anorexia nervosa and bulimia nervosa.
Read More
Recall that in October of 2003, the FDA issued a public health advisory about the possibility that antidepressants cause suicidal ideation in children and adolescents.
Read More
Most psychiatrists have at least heard of pramipexole (Mirapex) by now, and many of us have actually prescribed it. The Journal of Clinical Psychiatry recently published a short and sweet review of its potential uses in psychiatry.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three...